Latest News
- Min. Nadda Unveils ?13,000-Crore Bio-Pharma SHAKTI and Chemical Parks Push to Expand India’s Global Chemicals and Biologics Footprint
- Aurobindo Pharma Subsidiary Launches Generic Cancer Drug in US, Expands Oncology Portfolio in Global Generics Market
- KIMS Hospitals Introduces Adaptive Deep Brain Stimulation in India for Advanced Parkinson’s Treatment
CDSCO Seeks Immediate Industry Feedback to Tackle Regulatory Challenges and Boost Pharma Innovation
The regulator has invited pharmaceutical companies, research institutions, and healthcare professionals to highlight the challenges they face in areas such as drug approvals, compliance protocols, and market entry. By addressing these issues, CDSCO aims to enhance efficiency and create a more dynamic and responsive regulatory ecosystem.
- By Newsdesk
- New Delhi
- Jan 24, 2025
In a significant move aimed at advancing India’s pharmaceutical landscape, the Central Drugs Standard Control Organization (CDSCO) has called upon industry stakeholders to provide urgent input on the hurdles and opportunities within the current regulatory framework. The initiative is part of CDSCO's efforts to streamline processes without compromising the quality and safety of medical products.
The regulator has invited pharmaceutical companies, research institutions, and healthcare professionals to highlight the challenges they face in areas such as drug approvals, compliance protocols, and market entry. By addressing these issues, CDSCO aims to enhance efficiency and create a more dynamic and responsive regulatory ecosystem.
Stakeholders have long expressed concerns over delays, redundant compliance processes, and regulatory bottlenecks, which often impede timely patient access to critical medicines. This consultation seeks to resolve these obstacles and establish a framework that supports faster, more effective regulatory outcomes.
A core aspect of the initiative is to bolster domestic innovation, particularly in advanced fields like gene therapy, stem cell research, and personalized medicine. Recognizing India’s potential as a global pharmaceutical powerhouse, CDSCO is keen on fostering an environment where local innovators and research organizations can thrive.
The organization is specifically seeking recommendations on policy updates, regulatory reforms, and funding mechanisms that could expedite the development of cutting-edge medical technologies. Stakeholders are encouraged to propose solutions that strike a balance between fostering innovation and upholding patient safety and ethical standards.
CDSCO has urged stakeholders to submit their suggestions promptly, underscoring the importance of collective effort in shaping a regulatory framework that aligns with global best practices. Feedback received will play a critical role in driving policy decisions and reinforcing India’s position as a leader in pharmaceutical and biotechnological advancements.
For submission details and further information, stakeholders can connect with CDSCO through its official channels.